Integra LifeSciences Corporation
IART | NASDAQ
$15.59
+$0.37 (+2.43%)
At close: Sep 21, 2026, 4:00 PM ET
$17
+$1.41 (+9.04%)
Pre-market:
Sep 22, 2026, 6:19 AM ET
Market Data
Market Cap $1.21B
Enterprise Value $2.98B
Beta 1.21
Average Volume 956.47K
Shares Outstanding (Diluted) 78.17M
Shares Change YoY 2.23%
Institutional Ownership 97.20%
Exchange NASDAQ
ISIN US4579852082
Price Performance
Price Change 1M -6.5%
Price Change 3M -11.9%
Price Change 6M 63.3%
Price Change YTD 29.8%
Price Change 1Y 8.2%
Price Change 3Y -59.6%
Price Change 5Y -78.4%
1M CAGR (ann.) -9.6%
1Y CAGR (ann.) 1.4%
5Y CAGR (ann.) -25.8%
All-Time CAGR -0.9%
Valuation
PE Ratio -168.36
Forward PE 5.94
PEG Ratio -1.69
Forward PEG -27.34
PS Ratio 0.74
Forward PS 0.70
PB Ratio 1.15
P/FCF Ratio 31.29
P/Adj. FCF Ratio 44.35
P/OCF Ratio 14.30
EV/Sales 1.81
EV/EBIT 31.00
EV/EBITDA 14.14
EV/FCF 76.84
Earnings Yield -0.6%
FCF Yield 3.2%
Adj. FCF Yield 2.3%
Financial Health
Net Debt $1.59B
Total Debt $2.04B
Cash & Short-Term Investments $274.08M
Total Assets $3.59B
Current Ratio 3.40
Quick Ratio 1.98
Debt / Equity Ratio 1.94
Debt / EBITDA 9.68
Debt / FCF 52.62
OCF / Debt 0.04
Interest Coverage 6.82
Altman Z-Score 1.28
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 53.7%
Operating Profit Margin 39.8%
EBITDA Margin 15.1%
Net Profit Margin -0.4%
FCF Margin 2.4%
Adj. FCF Margin 1.7%
SBC / Revenue 0.7%
SBC Impact (per share) -29.5%
Returns
Return on Assets -0.2%
Return on Equity -0.7%
Return on Invested Capital 19.9%
Return on Capital Employed 20.3%
Return on Tangible Assets -0.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 2.2%
Revenue CAGR 5Y 1.8%
Revenue CAGR 10Y 5.6%
EPS CAGR 3Y -9.0%
EPS CAGR 5Y -217.7%
EPS CAGR 10Y -150.6%
FCF CAGR 3Y -37.0%
FCF CAGR 5Y -32.8%
FCF CAGR 10Y -6.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 26
EPS Growth Next 3Y 1144.4%
Revenue Growth Next 3Y 3.1%
Earnings Date Oct 28, 2026
EPS Estimate (next Q) $0.56
EPS Growth Est (next Q) 3.7%
Revenue Est (next Q) $416.3M
Revenue Growth Est (next Q) 3.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $20.50
Price Target Upside 31.5%
Cash Flow
Operating Cash Flow $85.33M
Free Cash Flow $38.76M
Adj. Free Cash Flow $27.34M
FCF Per Share $0.50
OCF Per Share $1.09
OCF/S Ratio 5.2%
Income Statement
Revenue $1.65B
Gross Profit $885.45M
Operating Income $655.86M
EBITDA $210.66M
Net Income $-7.24M
EPS (Diluted) -$0.09
Revenue / Employee $372.19K
Profit / Employee $-1.64K
Employees 4,427
Add to Watchlist
Select watchlists to add or remove IART